(NYSE:ESTC), NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Elastic N.V. (“Elastic” or the “Company”) (NYSE: ESTC) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-00785, is on […]

(NasdaqGM:IAS), NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQ: IAS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

(NASDAQ:QUBT), NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-01457, is on

(NYSE:ELF), NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against e.l.f. Beauty, Inc. (“Elf” or the “Company”) (NYSE: ELF) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-02316, is on

(NasdaqGM:GERN), NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Geron Corporation (“Geron” or the “Company”) (NASDAQ: GERN) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-02563, is on behalf

PARAMUS, N.J., March 26, 2025 (GLOBE NEWSWIRE) — Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today that the Company will present a poster at the American Association for Cancer Research (AACR) Annual Meeting 2025, taking place in Chicago, IL, from April 25-30, 2025.

(NASDAQ:WBA), NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) and certain officers. The class action, filed in the United States District Court for the Northern District of Illinois, and docketed under 25-cv-01058, is

(NASDAQ:MBX), CARMEL, Ind., March 26, 2025 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, will present at and participate in the 24th

(NASDAQ:ALGS), SOUTH SAN FRANCISCO, Calif., March 26, 2025 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced positive data from three oral presentations at the 34th Annual Meeting of the Asian Pacific Association

Jim Grogan and Kelly Riedel bring decades of leadership in corporate governance, automation, and logistics Lab0, a cutting-edge robotics and automation company, today announced the appointment of Jim Grogan and Kelly Riedel, to its Board of Directors. With deep expertise in corporate governance, automation, and logistics, these industry veterans will help guide Lab0's strategic direction